Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ORLY vs GSK✓SelectedUSD · GSKORLY vs GSK performance historyLatest closeAs of+0.73%11/18
Stock and ETF performance explorer

ORLY vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+58,104.6%
GSK return
+1,032.7%
Excess return
+57,071.9%
Maximum drawdown
-65.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.7%-1.3%+2.1%+1.1%
7D+3.1%-3.1%+6.3%+4.1%
30D+4.8%-0.9%+5.7%+5.0%
3M+2.9%-4.2%+7.0%+4.0%
6M+1.8%-1.6%+3.4%+1.9%
YTD+2.4%+2.6%-0.2%+0.8%
1Y-5.0%+6.2%-11.3%-7.4%
3Y+44.6%+55.0%-10.4%+23.8%
5Y+116.8%+42.8%+74.0%+87.6%
10Y+427.0%+102.1%+324.9%+310.2%
All+58,104.6%+1,032.7%+57,071.9%+36,846.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling